Dr. Susan Perez (right), ISPE President, recognizes Dr. Patricia Tennis (left) as an ISPE Fellow.

In recognition of her scientific contributions to pharmacoepidemiology Dr. Patricia Tennis was recently inducted as a Fellow in the International Society for Pharmacoepidemiology (ISPE). Dr. Tennis has over 18 years experience conducting pharmacoepidemiologic research at the University of North Carolina at Chapel Hill, Burroughs Wellcome and Co. / Glaxo Wellcome / GlaxoSmithKline, and RTI Health Solutions. She has been a member of ISPE since 1986, served on the Board of ISPE for three years, and has published regularly in the area of pharmacoepidemiology, particularly on quantifying the safety of medications in general clinical practice.

Dr. Tennis was instrumental in developing a program of pregnancy registries for antiepileptic medications and other medications. She has participated in FDA and CDC working groups that addressed the study of pharmaceutical exposures during pregnancy.

Dr. Tennis currently leads the epidemiology group at RTI Health Solutions and works closely with clients on retrospective and prospective studies, several of which have international scope. Among other responsibilities, she is currently the principal investigator for two claims-based studies quantifying the frequency of selected medical events in patients receiving specific medications and a project monitoring physician prescribing within the context of a risk management program.